Literature DB >> 9187206

Contamination of hospital compressed air with nitric oxide: unwitting replacement therapy.

M R Pinsky1, F Genc, K H Lee, E Delgado.   

Abstract

BACKGROUND: Inhaled nitric oxide (NO) at levels between 5 and 80 ppm has been used experimentally to treat a variety of conditions. NO also is a common environmental air pollutant in industrial regions. As compressed hospital air is drawn from the local environment, we speculated that it may contain NO contamination, which, if present, would provide unwitting inhaled NO therapy to all subjects respiring this compressed gas.
METHODS: NO levels were measured twice daily from ambient hospital air and compressed gas sources driving positive pressure ventilation from two adjacent hospitals and compared with NO levels reported daily by local Environmental Protection Agency sources. An NO chemiluminescence analyzer (Sievers 270B; Boulder, Colo) sensitive to > or =2 parts per billion was used to measure NO levels in ambient air and compressed gas.
RESULTS: NO levels in ambient air and hospital compressed air covaried from day to day, and absolute levels of NO differed between hospitals with the difference never exceeding 1.4 ppm (range, 0 to 1.4 ppm; median, 0.07 ppm). The hospital with the highest usage level of compressed air had the highest levels of NO, which approximated ambient levels of NO. NO levels were lowest on weekends in both hospitals. We also documented inadvertent NO contamination in one hospital occurring over 5 days, which corresponded to welding activity near the intake port for fresh gas. This contamination resulted in system-wide NO levels of 5 to 8 ppm.
CONCLUSION: Hospital compressed air contains highly variable levels of NO that tend to covary with ambient NO levels and to be highest when the rate of usage is high enough to preclude natural degradation of NO in 21% oxygen. Assuming that inhaled NO may alter gas exchange, pulmonary hemodynamics, and outcome from acute lung injury, the role of unwitting variable NO of hospital compressed air needs to be evaluated.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9187206     DOI: 10.1378/chest.111.6.1759

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  3 in total

Review 1.  Nasal nitric oxide in man.

Authors:  J O Lundberg; E Weitzberg
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

2.  Workplace NO and NO2 during combined treatment of infants with nasal CPAP and NO.

Authors:  Robert Lindwall; Mats E Svensson; Claes G Frostell; Staffan Eksborg; Lars E Gustafsson
Journal:  Intensive Care Med       Date:  2006-10-17       Impact factor: 17.440

3.  Onsite production of medical air: is purity a problem?

Authors:  Paul Edwards; Patricia-Ann Therriault; Ira Katz
Journal:  Multidiscip Respir Med       Date:  2018-05-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.